BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options
January 24, 2024 11:30 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in BioNTech stock or options between March 30, 2022 and October 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi...
BIONTECH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioNTech SE and Encourages Investors to Contact the Firm
January 17, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against...
BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options
January 17, 2024 11:30 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in BioNTech stock or options between March 30, 2022 and October 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi...
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent
July 27, 2021 08:20 ET
|
Dyadic International, Inc.
Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreementProvides potential funding pathway for a C1 manufactured COVID-19 vaccine to progress through Phase II and Phase III...
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
June 07, 2021 10:06 ET
|
AGC Biologics
Seattle, June 07, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech...
Cvent Event Technology Helps Organize Pfizer COVID-19 Vaccine Distribution
February 01, 2021 08:30 ET
|
Cvent
Tysons, VA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Today, Cvent, a market-leading meetings, events, and hospitality technology provider, announced that the University of Rochester Medical Center (URMC),...
UPS To Support Distribution Of Approved Vaccine As Part Of Operation Warp Speed
December 12, 2020 07:30 ET
|
UPS
ATLANTA, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Deployments began after federal mandate to distribute therapies within 24 hours of emergency use authorization.UPS to help transport the initial...
BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates Against Various Infectious Diseases
November 05, 2018 06:00 ET
|
BioNTech AG
BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates Against Various Infectious Diseases New research program between BioNTech...
BioNTech und die Universität Pennsylvania gehen strategische Forschungskooperationen ein, um mRNA-Impfstoffkandidaten gegen Infektionskrankheiten zu entwickeln
November 05, 2018 01:00 ET
|
BioNTech AG
BioNTech und die Universität Pennsylvania gehen strategische Forschungskooperationen ein, um mRNA-Impfstoffkandidaten gegen Infektionskrankheiten zu entwickeln Neues Forschungsprogramm zwischen...
BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates Against Various Infectious Diseases
November 05, 2018 01:00 ET
|
BioNTech AG
BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates Against Various Infectious Diseases New research program between BioNTech...